Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona and CIBER EHD, Avda Diagonal 645, Edifici annex, Planta-1, 08028 Barcelona, Spain.
Mol Pharmacol. 2010 Nov;78(5):795-803. doi: 10.1124/mol.110.065920. Epub 2010 Jul 19.
Human concentrative nucleoside transporter 3 (hCNT3) is a broad-selectivity, high-affinity protein implicated in the uptake of most nucleoside-derived anticancer and antiviral drugs. Regulated trafficking of hCNT3 has been recently postulated as a suitable way to improve nucleoside-based therapies. Moreover, the recent identification of a putative novel hCNT3-type transporter lacking the first 69 amino acids and retained at the endoplasmic reticulum anticipated that the N terminus of hCNT3 contains critical motifs implicated in trafficking. In the current study, we have addressed this issue by using deletions and site-directed mutagenesis and plasma membrane expression and nucleoside uptake kinetic analysis. Data reveal that 1) a segment between amino acids 50 and 62 contains plasma membrane-sorting determinants in nonpolarized cells; 2) in particular, the Val(57)-Thr(58)-Val(59) tripeptide seems to be the core of the export signal, whereas acidic motifs upstream and downstream of it seem to be important for the kinetics of the process; and 3) in polarized epithelia, the β-turn-forming motif (17)VGFQ(20) is necessary for proper apical expression of the protein.
人集中核苷转运蛋白 3(hCNT3)是一种广泛选择性、高亲和力的蛋白,与大多数核苷衍生的抗癌和抗病毒药物的摄取有关。最近有人提出,hCNT3 的调节性转运是改善基于核苷的治疗的合适方法。此外,最近鉴定出一种假定的新型 hCNT3 型转运蛋白,其缺乏前 69 个氨基酸并保留在内质网中,预计 hCNT3 的 N 端包含与转运有关的关键基序。在本研究中,我们通过使用缺失和定点突变以及质膜表达和核苷摄取动力学分析来解决这个问题。数据表明:1)氨基酸 50 至 62 之间的一段含有非极化细胞中质膜分拣决定因素;2)特别是,Val(57)-Thr(58)-Val(59)三肽似乎是出口信号的核心,而其上下游的酸性基序对于该过程的动力学很重要;3)在极化上皮中,β-转角形成基序(17)VGFQ(20)对于蛋白的正确顶端表达是必需的。